These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9191178)

  • 21. Prospects for specific immunotherapy in myasthenia gravis.
    Steinman L; Mantegazza R
    FASEB J; 1990 Jul; 4(10):2726-31. PubMed ID: 2197152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encephalopathy, peripheral neuropathy, dysautonomia, myasthenia gravis, malignant thymoma, and antiacetylcholine receptor antibodies in the CSF.
    Bogousslavsky J; Regli F; Doret AM; Fulpius BW; Ostinelli B; Rabinowicz T; Ruzicka J
    Eur Neurol; 1983; 22(5):301-6. PubMed ID: 6628458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosynthetic and synthetic AChR sequences to study T cells in myasthenia gravis.
    Diethelm-Okita B; Wells G; Kuryatov A; Okita D; Howard J; Lindstrom J; Conti-Fine BM
    Ann N Y Acad Sci; 1998 May; 841():320-3. PubMed ID: 9668250
    [No Abstract]   [Full Text] [Related]  

  • 25. Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma.
    Husain AM; Massey JM; Howard JF; Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():471-4. PubMed ID: 9668277
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma.
    Fujii Y; Monden Y; Nakahara K; Hashimoto J; Kawashima Y
    Neurology; 1984 Sep; 34(9):1182-6. PubMed ID: 6611521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies.
    Nagvekar N; Jacobson LW; Willcox N; Vincent A
    Clin Exp Immunol; 1998 Apr; 112(1):17-20. PubMed ID: 9566784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific involvement of peripheral T lymphocytes against acetylcholine receptors in myasthenia gravis.
    Conti-Tronconi BM; Scotti A; Sghirlanzoni A; Clementi F
    J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):832-6. PubMed ID: 6604791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metaplastic thymoma with myasthenia gravis presumably caused by an accumulation of intratumoral immature T cells: a case report.
    Tajima S; Yanagiya M; Sato M; Nakajima J; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(11):15375-80. PubMed ID: 26823897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The thymus and myasthenia gravis.
    Ragheb S; Lisak RP
    Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-specific immunotherapy in myasthenia gravis: failed promise and new hope.
    Pachner AR
    J Neuroimmunol; 2004 Jul; 152(1-2):vii-viii. PubMed ID: 15223253
    [No Abstract]   [Full Text] [Related]  

  • 33. Strategies for treatment of myasthenia gravis.
    Drachman DB; McIntosh KR; Reim J; Balcer L
    Ann N Y Acad Sci; 1993 Jun; 681():515-28. PubMed ID: 8357193
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunopathologic events at the endplate in myasthenia gravis.
    Ashizawa T; Appel SH
    Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity.
    Ahlberg R; Yi Q; Pirskanen R; Matell G; Swerup C; Rieber EP; Riethmüller G; Holm G; Lefvert AK
    Neurology; 1994 Sep; 44(9):1732-7. PubMed ID: 7936306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholine receptor epitope in proteins of myasthenia gravis-associated thymomas and non-thymic tissues.
    Marx A; O'Connor R; Tzartos S; Kalies I; Kirchner T; Müller-Hermelink HK
    Thymus; 1989; 14(1-3):171-8. PubMed ID: 2482999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenetic mechanisms in myasthenia gravis.
    Steinman L
    Prog Brain Res; 1990; 84():117-24. PubMed ID: 2267289
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of T-cells in the initiation of autoantibody responses in thymoma patients.
    Vincent A; Willcox N
    Pathol Res Pract; 1999; 195(8):535-40. PubMed ID: 10483583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The third Euromyasthenia Conference; meeting report and update on myasthenia research.
    Willcox N
    Autoimmunity; 1992; 11(3):209-12. PubMed ID: 1373962
    [No Abstract]   [Full Text] [Related]  

  • 40. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
    Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
    J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.